rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Ryan Ho-Yan Wong

Chief Financial Officer

Company insider

Files Form 4 as: Chief Financial Officer, Sarepta Therapeutics.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
31 Jul 2025
Last trade
4 Sep 2026
Last filed
8 Sep 2026

Companies traded

Where they are an officer
SRPT Sarepta TherapeuticsOfficer · Biotechnology · last 4 Sep 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
4 Sep 2026filed 8 Sep 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$295K13,272 at $22.22filing
4 Sep 2026filed 8 Sep 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$295K13,272 at $22.22filing
11 Mar 2026filed 13 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$4,360256 at $17.03filing
11 Mar 2026filed 13 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$4,360256 at $17.03filing
9 Mar 2026filed 11 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$2,746162 at $16.95filing
9 Mar 2026filed 11 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$1,915113 at $16.95filing
9 Mar 2026filed 11 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$2,746162 at $16.95filing
9 Mar 2026filed 11 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$1,915113 at $16.95filing
2 Mar 2026filed 3 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$7,290450 at $16.20filing
2 Mar 2026filed 3 Mar 2026SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$7,290450 at $16.20filing
1 Dec 2025filed 10 Dec 2025SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$1,67780 at $20.96filing
1 Dec 2025filed 10 Dec 2025SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$1,63578 at $20.96filing
3 Sep 2025filed 5 Sep 2025SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code A—93,875 at $0.00filing
3 Sep 2025filed 5 Sep 2025SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
31 Jul 2025filed 4 Aug 2025SRPT Sarepta TherapeuticsBiotechnologySEC FORM 4 Code F$5,369327 at $16.42filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Louise Rodino-KlapacPresident, R&D and Tech Ops · President, R&D and Tech Ops at Sarepta Therapeutics, filing Form 4 there in the last year
Ian Michael EstepanChief Operating Officer · Chief Operating Officer at Sarepta Therapeutics, filing Form 4 there in the last year
Cristin RothfussEVP, General Counsel · EVP, General Counsel at Sarepta Therapeutics, filing Form 4 there in the last year
Michael SeverinoChief Executive Officer · Chief Executive Officer at Sarepta Therapeutics, filing Form 4 there in the last year
Richard BarryPresident & CEO · Director at Sarepta Therapeutics, filing Form 4 there in the last year